Shares of YUNJI (02670) climbed more than 8% during intraday trading before paring gains, with the stock last up 3.27% at HK$90, recording a turnover of HK$15.77 million.

According to the company's official WeChat account, YUNJI's composite multipurpose robot UP has achieved its first 100-unit scale deployment in the healthcare sector, officially entering several top-tier Grade-A tertiary hospitals. The specialized delivery solution, branded "Runyi," was co-developed by partner Zhejiang Aida Technology based on UP's universal chassis and customized for hospital environments. Initial installations have gone live at Tongji Hospital's Optical Valley campus, Tianjin Nankai Hospital, and Yuyao Traditional Chinese Medicine Hospital, where the robots handle pharmaceutical delivery tasks across the facilities.

In the first half of 2026, revenue from YUNJI's ecosystem partners reached RMB 90.5 million, surging 3,302.1% year-over-year and representing 48.1% of total revenue, making it the company's largest revenue source. This significant growth in ecosystem partner revenue is directly attributed to UP's open strategy, which establishes a scalable product positioning of "standardized chassis plus partner-customized upper modules." This approach enables mass reuse of the same technology foundation across diverse scenarios, laying the groundwork for the company's accelerated cross-sector growth.